INTERNATIONAL BIOTECHNOLOGY TST PLC
IBT | IL
Overview
Corporate Details
- ISIN(s):
- GB0004559349
- LEI:
- 213800N1QUJ744P76D11
- Country:
- United Kingdom
- Address:
- 1 London Wall Place, EC2Y 5AU LONDON
- Website:
- https://www.ibtplc.com/
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
International Biotechnology Trust PLC invests in biotechnology companies to achieve long-term capital growth.
Market Data
Market Data Not Available
Last Price
Change / %
Market Cap
Market Cap data is planned for a future update.
N/A
Volume
Day High
Day Low
52W High
52W Low
Financials & KPIs
No data available
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
Chat, Summarize & Extract with AI!
You have of free filing views remaining.
Upgrade for unlimited access.
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-17 11:11 |
Net Asset Value(s)
Net Asset Value(s)
|
English | 7.5 KB | |
| 2025-06-16 11:25 |
Net Asset Value(s)
Net Asset Value(s)
|
English | 7.5 KB | |
| 2025-06-13 12:55 |
Net Asset Value(s)
Net Asset Value(s)
|
English | 7.5 KB | |
| 2025-06-11 11:27 |
Regulatory News Service
Net Asset Value(s)
|
English | 7.3 KB | |
| 2025-06-10 14:11 |
Regulatory News Service
Net Asset Value(s)
|
English | 7.5 KB | |
| 2025-06-05 18:09 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 4.9 KB | |
| 2025-06-05 11:33 |
Net Asset Value(s)
Net Asset Value(s)
|
English | 7.5 KB | |
| 2025-06-02 11:32 |
Net Asset Value(s)
Net Asset Value(s)
|
English | 7.5 KB | |
| 2025-05-30 18:47 |
Declaration of Voting Results & Voting Rights Announcements
Total Voting Rights
|
English | 4.8 KB | |
| 2025-05-30 11:16 |
Net Asset Value(s)
Net Asset Value(s)
|
English | 7.5 KB | |
| 2025-05-29 11:10 |
Net Asset Value(s)
Net Asset Value(s)
|
English | 7.5 KB | |
| 2025-05-28 17:55 |
Transaction in Own Shares
Transaction in Own Shares
|
English | 3.2 KB | |
| 2025-05-28 11:35 |
Net Asset Value(s)
Net Asset Value(s)
|
English | 7.5 KB | |
| 2025-05-27 16:52 |
Interim Report
Half Year Report
|
English | 4.8 MB | |
| 2025-05-27 11:10 |
Net Asset Value(s)
Net Asset Value(s)
|
English | 7.5 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
OSE Immunotherapeutics | France | OSE | |
|
Ovoca Bio Plc | Ireland | OVXA | |
|
Oxford Biomedica PLC | United Kingdom | OXB | |
|
OXFORD CANNABINOID TECHNOLOGIES HOLDINGS PLC | United Kingdom | OCTHF | |
|
Oxurion NV | Belgium | OXUR | |
|
PCI Biotech Holding | Norway | PCIB | |
|
Pentixapharm Holding AG | Germany | PTP | |
|
Perpetua Medical AB | Sweden | PERP | |
|
PharmaLundensis AB | Sweden | PHAL | |
|
Pharma Mar S.A. | Spain | PHM |